Stina Söderlund
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
-
- Immune cells in cancer
- Mast cells and histamine
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Hematology 21
- Chronic Myeloid Leukemia Treatments 21
-
- Immune Cell Function and Interaction 2
- Immune cells in cancer 2
- Mast cells and histamine 2
- Co-authors
- Ulla Olsson‐Strömberg (13 shared papers)Johan Richter (12 shared papers)Satu M. Mustjoki (8 shared papers)Lisa H. Christiansson (3 shared papers)Berit Markevärn (9 shared papers)Angelica Loskog (3 shared papers)Leif Stenke (9 shared papers)Bengt Simonsson (3 shared papers)
In The Last Decade
Stina Söderlund
25 papers receiving 1.1k citations
Stina Söderlund's Hit Papers
Peers
Comparison fields: 5 of 43
- Hematology 854
- Immunology 129
- Oncology 63
- Genetics 23
- Modeling and Simulation 7
Countries citing papers authored by Stina Söderlund
This map shows the geographic impact of Stina Söderlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stina Söderlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stina Söderlund more than expected).
Fields of papers citing papers by Stina Söderlund
This network shows the impact of papers produced by Stina Söderlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stina Söderlund. The network helps show where Stina Söderlund may publish in the future.
Co-authors
The 25 scholars most cited alongside Stina Söderlund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial Hit paper breakdown → | 2018 | 487 |
| 2 | 2014 | 114 | |
| 3 | 2013 | 113 | |
| 4 | 2015 | 61 | |
| 5 | 2014 | 60 | |
| 6 | 2024 | 40 | |
| 7 | 2019 | 27 | |
| 8 | 2021 | 23 | |
| 9 | 2019 | 22 | |
| 10 | 2016 | 21 | |
| 11 | 2022 | 17 | |
| 12 | 2013 | 14 | |
| 13 | 2016 | 12 | |
| 14 | 2021 | 11 | |
| 15 | 2024 | 11 | |
| 16 | 2015 | 10 | |
| 17 | 2014 | 9 | |
| 18 | 2021 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2020 | 7 |
About Stina Söderlund
Stina Söderlund is a scholar working on Hematology, Immunology, Pharmacology, Oncology and Nuclear Energy and Engineering, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (21 papers), Immune Cell Function and Interaction (2 papers), Immune cells in cancer (2 papers), Mast cells and histamine (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Hematology (854 citations), Immunology (129 citations), Oncology (63 citations), Genetics (23 citations) and Modeling and Simulation (7 citations). Stina Söderlund has collaborated with scholars based in Sweden, Finland and Norway. Frequent co-authors include Ulla Olsson‐Strömberg, Johan Richter, Satu M. Mustjoki, Lisa H. Christiansson, Berit Markevärn, Angelica Loskog, Leif Stenke, Bengt Simonsson, Anna Lübking and Mats Bengtsson. Their work appears in journals such as Blood, European Journal Of Haematology, Leukemia, Leukemia Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.